Pharmacokinetics of Mycophenolate Mofetil in de novo lung allograft recipients

Trial Profile

Pharmacokinetics of Mycophenolate Mofetil in de novo lung allograft recipients

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Feb 2017

At a glance

  • Drugs Mycophenolate mofetil (Primary)
  • Indications Lung transplant rejection
  • Focus Pharmacokinetics; Registrational
  • Acronyms CELMACS
  • Sponsors Roche
  • Most Recent Events

    • 07 Jul 2012 Last checked against European Clinical Trials Database record.
    • 06 Jun 2012 Status changed from active, no longer recruiting to completed, according to EudraCT record.
    • 18 Dec 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top